Skip to main content
    Z

    Zoetis Inc (ZTS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $83.47
    -0.92 (-1.08%)

    Market Cap: $34.29B

    Last updated: Nov 17, 2026 at 4:59 PM ET

    Zoetis Inc (ZTS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Zoetis (ZTS) has a market cap of $34.29B and an enterprise value of $42.01B. Its trailing P/E of 12.6x is below its 10-year median of 31.9x. Its share count is down 7.07% from a year earlier.

    Total Valuation

    Enterprise value is 22.50% above the market cap, as debt exceeds cash.

    Market Cap$34.29B
    Enterprise Value$42.01B
    Latest price (Nov 17, 2026)$83.47

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Oct 30, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Last Ex-Dividend DateOct 30, 2026
    Next Payment DateDec 1, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 1.44% in the quarter ended Sep 30, 2026 and shrank 4.67% a year over 2 years.

    Shares Outstanding411.60M
    Shares Change (YoY)-7.07%
    Shares Change (QoQ)-1.44%
    Share Count Growth (2Y CAGR)-4.67%

    Valuation Ratios

    Sales and book value multiples are 3.6x and 10.4x. Its year-end P/E ranged from 19.6x to 51.9x from 2016 to 2025.

    P/E Ratio12.6x
    Forward P/E13.0x
    P/S Ratio3.6x
    Forward P/S3.7x
    P/B Ratio10.4x
    P/FCF Ratio15.1x
    P/OCF Ratio12.4x
    PEG Ratio1.5

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 11.0x EBITDA and 18.5x free cash flow.

    EV / Earnings16.9x
    EV / Sales4.4x
    EV / EBITDA11.0x
    EV / EBIT12.5x
    EV / FCF18.5x

    Price Statistics

    The stock is down 29.83% over 52 weeks and trades 9.40% above its 50-day average.

    Beta (1Y)0.60
    52-Week Change-29.83%
    1-Month Change+5.58%
    3-Month Change+9.59%
    6-Month Change+6.51%
    5-Year Change-63.13%
    10-Year Change+66.78%
    Total Return (1Y)-28.05%
    Total Return (3Y CAGR)-20.82%
    Total Return (5Y CAGR)-17.13%
    Return vs SPY (1Y)-39.80%
    Max Drawdown (1Y)-47.05%
    Max Drawdown (3Y)-64.40%
    Sharpe Ratio (1Y)-0.84
    Correlation with SPY (1Y)0.21
    50-Day Average$76.30
    200-Day Average$90.29
    52-Week Range$68.31 to $130.12
    RSI (14 Days)57.8
    Average Volume (20 Days)4.56M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.35x current liabilities, and total debt is 2.74x shareholder equity.

    Current Ratio2.35x
    Quick Ratio1.40x
    Debt / Equity2.74x
    Debt / EBITDA2.36x
    Debt / FCF3.97x
    Interest Coverage13.87x

    Returns and Efficiency

    Return on invested capital is 21.69% over the last 12 months, against a 5-year average of 21.37%.

    Return on Equity (ROE)75.26%
    Return on Assets (ROA)16.48%
    Return on Invested Capital (ROIC)21.69%
    Return on Capital Employed (ROCE)27.05%
    ROE (5Y Average)54.02%
    ROA (5Y Average)15.99%
    ROIC (5Y Average)21.37%
    Asset Turnover0.63x
    Inventory Turnover1.07x
    Receivables Turnover5.83x
    Cash Conversion Cycle347 days

    Taxes

    Income tax took 20.17% of pretax income over the last 12 months.

    Income Tax (TTM)$628.00M
    Effective Tax Rate20.17%

    Scores

    ZTS has an Altman Z-Score of 4.82, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score4.82
    Altman Z ZoneSafe
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $9.51B over the last 12 months is up 1.03% from the 12 months before.

    Revenue$9.51B
    Revenue Growth (YoY)+1.03%
    Gross Profit$6.78B
    Operating Income$3.39B
    Pretax Income$3.11B
    Net Income$2.49B
    EBITDA$3.83B
    EBIT$3.36B
    Reported EPS (TTM)$6.63

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 21.87% of the $15.09B in total assets.

    Cash and Equivalents$1.33B
    Total Debt$9.05B
    Net Debt$7.72B
    Net Debt Per Share$18.75
    Working Capital$3.61B
    Shareholder Equity$3.30B
    Book Value Per Share$8.02
    Tangible Book Value-$435.00M
    Total Assets$15.09B
    Total Liabilities$11.79B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $495.00M of capital spending, operating cash flow left $2.28B of free cash flow.

    Operating Cash Flow$2.77B
    Capital Expenditures$495.00M
    Free Cash Flow$2.28B
    FCF Per Share$5.51
    Depreciation and Amortization$478.00M
    Dividends Paid$886.00M
    Share Repurchases$3.75B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 35.70%, against a 5-year average of 36.09%.

    Gross Margin71.35%
    Operating Margin35.70%
    Pretax Margin32.75%
    Net Margin26.15%
    EBITDA Margin40.32%
    EBIT Margin35.30%
    FCF Margin23.96%
    Gross Margin (5Y Average)70.50%
    Operating Margin (5Y Average)36.09%
    Net Margin (5Y Average)26.97%

    Growth

    Revenue grew 5.42% a year over 3 years, and EPS 9.57% a year.

    Revenue Growth (3Y CAGR)+5.42%
    Revenue Growth (5Y CAGR)+7.24%
    EPS Growth (3Y CAGR)+9.57%
    EPS Growth (5Y CAGR)+10.77%
    FCF Growth (3Y CAGR)+19.85%
    FCF Growth (5Y CAGR)+6.41%
    Operating Income Growth (3Y CAGR)+6.73%
    Book Value Per Share Growth (2Y CAGR)-15.33%

    Revenue and profit by year

    Dividends and Yields

    ZTS pays out 31.47% of earnings as dividends.

    Dividend Per Share (Annual)$2.12
    Dividend Yield2.54%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+15.44%
    Dividend Growth (5Y CAGR)+20.11%
    Payout Ratio31.47%
    FCF Payout Ratio38.89%
    Earnings Yield7.94%
    FCF Yield6.63%
    Buyback Yield10.91%
    Shareholder Yield13.49%

    Full dividend history

    Peer Position

    Against 10 similar companies, ZTS has the 9th highest P/E and the 2nd highest ROIC.

    P/E Ratio12.6x vs 21.7x median
    P/S Ratio3.6x vs 2.7x median
    ROIC21.69% vs 8.65% median
    Revenue Growth (Trailing 4 Quarters, YoY)+1.03% vs +8.88% median
    Dividend Yield2.54% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -0.68% and EPS growth at -0.33% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-0.68%
    EPS Growth Forecast (2Y CAGR)-0.33%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ZTS

    What is ZTS's market cap?

    Zoetis has a market cap of $34.29B. Its enterprise value, which adds debt and subtracts cash, is $42.01B.

    What is ZTS's P/E ratio?

    Zoetis has a trailing P/E ratio of 12.6x and a forward P/E of 13.0x.

    How many shares of ZTS are outstanding?

    Zoetis has 411.60M shares outstanding. The count is down 7.07% from a year earlier.

    Does ZTS pay a dividend?

    Yes. Zoetis pays $2.12 a share a year, a dividend yield of 2.54%.

    How much debt does ZTS have?

    Zoetis has $9.05B of total debt and $1.33B of cash and equivalents, a net debt position of $7.72B.